Because PFK1 is a rate-limiting enzyme, tumor cells compensate for the decreased activity of PFK1 by upregulating the expression of the downstream crucial enzyme PKM2, which increases the efficiency of glycolysis (Pinweha et al., 2016). Here, PKM is linked to neoplasm.